Akcea Therapeutics, Inc. Accrued Liabilities, Current
Akcea Therapeutics, Inc. had Accrued Liabilities, Current of $12.32 million as of 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2020-08-05
- 2020-06-30: Accrued Liabilities, Current $12.32M.
- 2020-03-31: Accrued Liabilities, Current $14.13M.
- 2019-12-31: Accrued Liabilities, Current $14.19M.
- 2019-09-30: Accrued Liabilities, Current $15.21M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2020-06-30 | $12.32M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $14.13M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $14.19M 10-Q · filed 2020-08-05 |
| 2019-09-30 | $15.21M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $17.57M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $17.25M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $14.79M 10-K · filed 2020-03-02 |
| 2018-09-30 | $21.15M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $25.97M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $13.41M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $7.57M 10-K · filed 2019-03-01 |
| 2017-09-30 | $3.45M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $2.21M 10-Q · filed 2017-08-09 |
| 2016-12-31 | $1.04M 8-K · filed 2018-09-18 |